These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 12140141

  • 1. Vinorelbine plus cisplatin versus cisplatin plus vindesine and mitomycin C in stage IIIB-IV non-small cell lung carcinoma: a prospective randomized study.
    Gebbia V, Galetta D, Riccardi F, Gridelli C, Durini E, Borsellino N, Gebbia N, Valdesi M, Caruso M, Valenza R, Pezzella G, Colucci G, Gruppo Oncologico Italia Meridionale.
    Lung Cancer; 2002 Aug; 37(2):179-87. PubMed ID: 12140141
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multicenter randomized trial comparing cisplatin-mitomycin-vinorelbine versus cisplatin-mitomycin-vindesine in advanced non-small cell lung cancer. 'Groupe Français de Pneumo-Cancérologie'.
    Pérol M, Guérin JC, Thomas P, Poirier R, Carles P, Robinet G, Kleisbauer JP, Paillotin D, Vergnenègre A, Balmes P, Touron D, Grivaux M, Pham E.
    Lung Cancer; 1996 Feb; 14(1):119-34. PubMed ID: 8696715
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T, Pujol JL, Douillard JY, Alberola V, Monnier A, Riviere A, Lianes P, Chomy P, Cigolari S, Besson F.
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).
    Crinò L, Clerici M, Figoli F, Carlini P, Ceci G, Cortesi E, Carpi A, Santini A, Di Costanzo F, Boni C.
    Ann Oncol; 1995 Apr; 6(4):347-53. PubMed ID: 7619749
    [Abstract] [Full Text] [Related]

  • 11. [Vinorelbine plus cisplatin in the treatment of advanced non-small cell lung cancer previously treated with taxane-based chemotherapy].
    Zhang W, Cao JN, Yin JL, Hong XN, Xu LG.
    Zhonghua Zhong Liu Za Zhi; 2003 Nov; 25(6):587-9. PubMed ID: 14690569
    [Abstract] [Full Text] [Related]

  • 12. A randomized phase II study of docetaxel or vinorelbine in combination with cisplatin against inoperable, chemo-naïve non-small-cell lung cancer in Taiwan.
    Chen YM, Perng RP, Shih JF, Tsai CM, Whang-Peng J.
    Lung Cancer; 2007 Jun; 56(3):363-9. PubMed ID: 17306906
    [Abstract] [Full Text] [Related]

  • 13. Amifostine plus cisplatin plus vinorelbine in the treatment of advanced non small cell lung cancer: a multicenter phase II study.
    Gridelli C, Cigolari S, Maiorino A, Ianniello GP, Brancaccio L, Rossi A, De Cataldis G, Pedicini T, Maiorino L, Barletta E, Di Lanno M, Bilancia D, Crispino C, Barzelloni ML, Masullo P, D'Aniello R, Manzione L.
    Lung Cancer; 2000 Jun; 28(3):237-44. PubMed ID: 10812192
    [Abstract] [Full Text] [Related]

  • 14. Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel-cisplatin versus vinorelbine-cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study.
    Douillard JY, Gervais R, Dabouis G, Le Groumellec A, D'Arlhac M, Spaeth D, Coudert B, Caillaud D, Monnier A, Clary C, Maury B, Mornet M, Rivière A, Clouet P, Couteau C.
    Ann Oncol; 2005 Jan; 16(1):81-9. PubMed ID: 15598943
    [Abstract] [Full Text] [Related]

  • 15. Multicenter randomized clinical trial on high-dose epirubicin plus cis-platinum versus vinorelbine plus cis-platinum in advanced non small cell lung cancer.
    Martoni A, Guaraldi M, Piana E, Strocchi E, Petralia A, Busutti L, Preti P, Robustelli G, Raimondi M, Ferrara G, Palomba G, Lelli G, Picece V, Recaldin E, Caffo O, Ambrosini G, Sarobba G, Farris A, Pannuti F.
    Lung Cancer; 1998 Oct; 22(1):31-8. PubMed ID: 9869105
    [Abstract] [Full Text] [Related]

  • 16. Randomized study of vinorelbine (VRB) versus vindesine (VDS) in previously untreated stage IIIB or IV non-small-cell lung cancer (NSCLC). The Japan Vinorelbine Lung Cancer Cooperative Study Group.
    Furuse K, Fukuoka M, Kuba M, Yamori S, Nakai Y, Negoro S, Katagami N, Takada Y, Kinuwaki E, Kawahara M, Kubota K, Sakuma A, Niitani H.
    Ann Oncol; 1996 Oct; 7(8):815-20. PubMed ID: 8922195
    [Abstract] [Full Text] [Related]

  • 17. Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
    Segawa Y, Kiura K, Takigawa N, Kamei H, Harita S, Hiraki S, Watanabe Y, Sugimoto K, Shibayama T, Yonei T, Ueoka H, Takemoto M, Kanazawa S, Takata I, Nogami N, Hotta K, Hiraki A, Tabata M, Matsuo K, Tanimoto M.
    J Clin Oncol; 2010 Jul 10; 28(20):3299-306. PubMed ID: 20530281
    [Abstract] [Full Text] [Related]

  • 18. Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer.
    Clark JI, Kancharla K, Qamar R, Fisher S, Hantel A, Panganiban J, Millbrandt L, Albain KS.
    Lung Cancer; 2001 Nov 10; 34(2):271-7. PubMed ID: 11679186
    [Abstract] [Full Text] [Related]

  • 19. Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
    Comella P, Frasci G, De Cataldis G, Panza N, Cioffi R, Curcio C, Belli M, Bianco A, Ianniello G, Maiorino L, Della Vittoria M, Perchard J, Comella G.
    Br J Cancer; 1996 Dec 10; 74(11):1805-11. PubMed ID: 8956797
    [Abstract] [Full Text] [Related]

  • 20. A phase II study of vinorelbine, mitomycin C and cisplatin chemotherapy for advanced non-small cell lung cancer.
    Kwon MR, Jeong TY, Yuh YJ, Kim SR.
    Korean J Intern Med; 2002 Dec 10; 17(4):240-4. PubMed ID: 12647638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.